Morten Tulstrup

672 total citations
17 papers, 339 citations indexed

About

Morten Tulstrup is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Morten Tulstrup has authored 17 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 7 papers in Hematology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Morten Tulstrup's work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Morten Tulstrup is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Morten Tulstrup collaborates with scholars based in Denmark, Sweden and Norway. Morten Tulstrup's co-authors include Kirsten Grønbæk, Kjeld Schmiegelow, Claus Henrik Nielsen, Karina Banasik, Søren Brunak, Birgitte Klug Albertsen, Janna Nissen, Henrik Ullum, Sisse Rye Ostrowski and Ulla Feldt‐Rasmussen and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Morten Tulstrup

16 papers receiving 336 citations

Peers

Countries citing papers authored by Morten Tulstrup

Since Specialization

Citations

This map shows the geographic impact of Morten Tulstrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Tulstrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Tulstrup more than expected).

Fields of papers citing papers by Morten Tulstrup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Tulstrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Tulstrup. The network helps show where Morten Tulstrup may publish in the future.

Co-authorship network of co-authors of Morten Tulstrup

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Tulstrup. A scholar is included among the top collaborators of Morten Tulstrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Tulstrup. Morten Tulstrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Title	Journal	Authors	Indexed citations
1	Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with <i>TET2</i>, <i>IDH2</i>, or <i>DNMT3A</i> mutations	Haematologica	Morten Tulstrup, Jakob Werner Hansen et al.	1
2	Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma	Leukemia	Simon Husby, Morten Tulstrup et al.	0
3	Impact of U2AF1 mutations on circular RNA expression in myelodysplastic neoplasms	Leukemia	Ulvi Ahmadov, Thomas B. Hansen et al.	7
4	Overall Survival in Patients with Ccus Depends on Presence of Anemia	Blood	Morten Tulstrup, Andreas Due Ørskov et al.	1
5	A predictive model for bone marrow disease in cytopenia based on noninvasive procedures	Blood Advances	Morten Tulstrup, Jack B. Cowland et al.	5
6	Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins	HemaSphere	Mette Soerensen, Morten Tulstrup et al.	6
7	TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis	Nature Communications	Morten Tulstrup, Mette Soerensen et al.	53
8	Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients	Scientific Reports	Sofie Bliddal, Karina Banasik et al.	128
9	Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia	Thrombosis Research	Rikke Linnemann Nielsen, Ramneek Gupta et al.	3
10	Effects of NT5C2 Germline Variants on 6‐Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia	Clinical Pharmacology & Therapeutics	Chuang Jiang, Wenjian Yang et al.	7
11	Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia – A NOPHO ALL2008 study	Thrombosis Research	Marissa LeBlanc, Morten Tulstrup et al.	16
12	Single Nucleotide Polymorphisms and Thromboembolism in Acute Lymphoblastic Leukemia — a NOPHO ALL2008 Study	Blood	Morten Tulstrup, Ellen Ruud et al.	1
13	Genetic predisposition to PEG‐asparaginase hypersensitivity in children treated according to NOPHO ALL2008	British Journal of Haematology	Benjamin Ole Wolthers, Morten Tulstrup et al.	32
14	A qualitative study of decision‐making on PhaseIIIrandomized clinical trial participation in paediatric oncology: Adolescents’ and parents’ perspectives and preferences	Journal of Advanced Nursing	Morten Tulstrup, Kjeld Schmiegelow et al.	20
15	Individualized 6‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial	European Journal Of Haematology	Morten Tulstrup, Thomas Leth Frandsen et al.	7
16	Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol	Leukemia	Benjamin Ole Wolthers, Thomas Leth Frandsen et al.	43
17	Parents’ and Adolescents’ Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials	Pediatric Blood & Cancer	Morten Tulstrup, Hanne Bækgaard Larsen et al.	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact